SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-23-095107
Filing Date
2023-12-12
Accepted
2023-12-12 16:15:49
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea189833-f3_canfite.htm F-3 362443
2 OPINION OF DORON, TIKOTZKY, KANTOR, GUTMAN, NESS, AMIT GROSS AND CO., ISRAELI CO ea189833ex5-1_canfite.htm EX-5.1 36562
3 CONSENT OF KOST FORER GABBAY & KASIERER ea189833ex23-1_canfite.htm EX-23.1 3095
4 FILING FEE TABLE ea189833ex-fee_canfite.htm EX-FILING FEES 18680
5 GRAPHIC image_001.jpg GRAPHIC 7097
6 GRAPHIC ex5-1_001.jpg GRAPHIC 5202
  Complete submission text file 0001213900-23-095107.txt   439024
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-276000 | Film No.: 231481418
SIC: 2834 Pharmaceutical Preparations